Dec 15 (Reuters) - Alligator Bioscience AB ATORX.ST :
* ALLIGATOR CARRIES OUT A FULLY GUARANTEED RIGHTS ISSUE OF
APPROXIMATELY SEK 86M
* SUBSCRIPTION PRICE: SEK 6.0 PER SHARE
* SUBSCRIPTION UNDERTAKINGS AMOUNT TO APPROXIMATELY SEK 12.6
MILLION, CORRESPONDING TO APPROXIMATELY 15 PERCENT OF RIGHTS
ISSUE
* HAS PROCURED GUARANTEE COMMITMENTS OF ABOUT SEK 73
MILLION,
WHICH SECURES RIGHTS ISSUE TO 100%
* ALLIGATOR WILL USE ISSUE PROCEEDS FROM RIGHTS ISSUE TO
START AND
RUN PHASE II STUDIES FOR MITAZALIMAB AS WELL AS COMPLETE PHASE I
STUDIES AND BEGIN WORK ON PHASE II STUDIES FOR ATOR-1017
Source text for Eikon: ID:nWkr5zGqtH
Further company coverage: ATORX.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))